Never miss a great news story! Get instant notifications from Economic Times Allow Not now. Glenmark Pharma launches generic version of asthma drug in Denmark. Glenmark launches generic when does januvia go off patent pending of Zetia in US market. Choose your reason below and click on the Report button.
This will alert our moderators to take action. Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings. NIFTY 50 10, Drag according januvia your convenience. This comes as a surprise as Sun has partnered the US based MSD in the domestic market to sue Glenmark for the patent infringement on the same drug. Indian drugmaker Sun Pharma received a tentative approval from the US drug regulator for generic when does januvia go off patent pending of When does januvia go off patent pending late last week, fuelling speculation among analysts that the company has challenged the patent on the blockbuster anti-diabetes drug.
The earliest off patent Sun can when does januvia go off patent pending the generic version of the drug is in However, industry experts say an application filed when does januvia go off patent pending to 14 years before pending patents for the drug are set to expire is most likely to be a Para IV application.
While patent related to Januvia basic compound is set to expire onpatents related to the salt or product the monophosphate version pending is marketed will only expire in in the US. Two other generic here which have filed their application around the same time are US based generic giant Mylan and Sandoz, the generic arm of Swiss drugmaker Novartis. Filing of or tentative approval by USFDA does not provide a right to put the generic product sought in the ANDA on the market till the patent expiry date, which in this case is Earlier this month, MSD sued Glenmark alleging that click its recently launched anti-diabetes drugs infringe its patent pending of drugs Januvia and Janumet.
Are you a Business Owner? Read more on patent. Sun Pharmaceutical Industries Ltd.
My Saved Articles Sign in Sign up. Find this comment offensive? This will alert our moderators to take action Name Reason for reporting: Foul language Slanderous Inciting hatred against a certain community Others.
Your Reason has been Reported to the admin. To see when does saved stories, click on link hightlighted in bold. Fill in your details: Will be displayed Will not be displayed Will be displayed.
Last week, the US giant sued Glenmark saying it is acting unlawfully by selling generic forms of Januvia sitagliptin and Janumet sitagliptin plus metformin as the patents protecting them are still valid. The Indian drugmaker says its just-launched drugs, called Zita and Zita Met, do not infringe any of Merck's patents in India,.
There is a precedent case Roche vs. Cipla which says that one can be non-infringing to a product patent if they are making the polymorph or salt which is claimed in the other patent application filed in parallel with the product patent application. I hope you remember the judgement of the case between Roche vs.
Januvia is a brand name of sitagliptin , approved by the FDA in the following formulation s:. There is currently no therapeutically equivalent version of Januvia available in the United States. Fraudulent online pharmacies may attempt to sell an illegal generic version of Januvia.
2018 ©